|
|
Volumn 4, Issue 2, 2005, Pages 105-
|
|
Coordinated effort targets resistance
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DAPIVIRINE;
DELAVIRDINE;
EFAVIRENZ;
ETRAVIRINE;
NEVIRAPINE;
PYRIMIDINE DERIVATIVE;
RILPIVIRINE;
RNA DIRECTED DNA POLYMERASE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
UNCLASSIFIED DRUG;
VIRUS ENZYME;
ANTIBIOTIC RESISTANCE;
CLINICAL TRIAL;
CRYSTAL STRUCTURE;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MECHANISM;
DRUG PROTEIN BINDING;
DRUG RESEARCH;
DRUG SYNTHESIS;
ENZYME INHIBITION;
GENE MUTATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MOLECULAR MODEL;
NOTE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
PROCESS OPTIMIZATION;
SIDE EFFECT;
STRUCTURE ANALYSIS;
VIROLOGY;
WILD TYPE;
|
|
EID: 14044268857
PISSN: 14741776
EISSN: None
Source Type: Journal
DOI: 10.1038/nrd1639 Document Type: Note |
|
Times cited : (2)
|
|
References (1)
|
